Barrett-Lee P - Search Results

1

Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response.

Lazaro G, Smith C, Goddard L, Jordan N, McClelland R, Barrett-Lee P, Nicholson RI, Hiscox S. Lazaro G, et al. Endocr Relat Cancer. 2013 Aug 28;20(5):691-704. doi: 10.1530/ERC-13-0019. Print 2013 Oct. Endocr Relat Cancer. 2013. PMID: 23900794

2

Characterization of estrogen receptor messenger RNA in human breast cancer.

Barrett-Lee PJ, Travers MT, McClelland RA, Luqmani Y, Coombes RC. Barrett-Lee PJ, et al. Cancer Res. 1987 Dec 15;47(24 Pt 1):6653-9. Cancer Res. 1987. PMID: 3677099

3

Experiences of men with breast cancer: an exploratory focus group study.

Williams BG, Iredale R, Brain K, France E, Barrett-Lee P, Gray J. Williams BG, et al. Br J Cancer. 2003 Nov 17;89(10):1834-6. doi: 10.1038/sj.bjc.6601305. Br J Cancer. 2003. PMID: 14612888 Free PMC article.

4

Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment.

Gee JM, Howell A, Gullick WJ, Benz CC, Sutherland RL, Santen RJ, Martin LA, Ciardiello F, Miller WR, Dowsett M, Barrett-Lee P, Robertson JF, Johnston SR, Jones HE, Wakeling AE, Duncan R, Nicholson RI. Gee JM, et al. Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S1-7. doi: 10.1677/erc.1.01054. Endocr Relat Cancer. 2005. PMID: 16113086 Review.

5

Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: a review of chemotherapy.

Barrett-Lee PJ. Barrett-Lee PJ. Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S125-33. doi: 10.1677/erc.1.01024. Endocr Relat Cancer. 2005. PMID: 16113089 Review.

6

Measurement of estrogen receptor status by immunocytochemistry in paraffin wax sections.

Jasani B, Douglas-Jones A, Rhodes A, Wozniak S, Barrett-Lee PJ, Gee J, Nicholson R. Jasani B, et al. Methods Mol Med. 2006;120:127-46. doi: 10.1385/1-59259-969-9:127. Methods Mol Med. 2006. PMID: 16491599

7

Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells.

Borley AC, Hiscox S, Gee J, Smith C, Shaw V, Barrett-Lee P, Nicholson RI. Borley AC, et al. Breast Cancer Res. 2008;10(6):R103. doi: 10.1186/bcr2206. Epub 2008 Dec 4. Breast Cancer Res. 2008. PMID: 19055788 Free PMC article.

8

Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring.

Jones AL, Barlow M, Barrett-Lee PJ, Canney PA, Gilmour IM, Robb SD, Plummer CJ, Wardley AM, Verrill MW. Jones AL, et al. Br J Cancer. 2009 Mar 10;100(5):684-92. doi: 10.1038/sj.bjc.6604909. Br J Cancer. 2009. PMID: 19259090 Free PMC article.

9

Aromatase inhibitors in breast cancer.

Hiscox S, Davies EL, Barrett-Lee P. Hiscox S, et al. Maturitas. 2009 Aug 20;63(4):275-9. doi: 10.1016/j.maturitas.2009.05.008. Epub 2009 Jul 3. Maturitas. 2009. PMID: 19577386 Review.

10

Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells.

Hiscox S, Barnfather P, Hayes E, Bramble P, Christensen J, Nicholson RI, Barrett-Lee P. Hiscox S, et al. Breast Cancer Res Treat. 2011 Feb;125(3):659-69. doi: 10.1007/s10549-010-0857-4. Epub 2010 Mar 31. Breast Cancer Res Treat. 2011. PMID: 20354780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters